Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.062354
+0.0072 (12.96%)
Apr 28, 2026, 12:42 PM EST
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $515.69 thousand as of April 28, 2026. Its market cap has decreased by -61.21% in one year.
Market Cap
515.69K
Enterprise Value
978.69K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 515.69K, a decrease of -98.35%. That is a compound annual growth rate of -20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 515.69K | -7.00% |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SQZ Biotechnologies Company | 707.79K |
| Eloxx Pharmaceuticals | 659.35K |
| Emmaus Life Sciences | 624.68K |
| Altamira Therapeutics | 513.82K |
| EV Biologics | 511.27K |
| Aibotics | 510.93K |
| Sorrento Therapeutics | 489.34K |
| Hepion Pharmaceuticals | 476.43K |